About Io Therapeutics
Io Therapeutics is a private company based in Spring, Texas. It has reported $4,601,501 raised in two offerings on Form D since January 2014. Its chief executive is Martin Sanders.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 28, 2023 | Mar 9, 2023amended Aug 3, 2023 | $4,158,000fully sold | 19 | $218K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Dec 20, 2013 | Jan 2, 2014 | $443,501of $1.0M target | 4 | $110K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $4,601,501 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Io Therapeutics's Form D filed Aug 3, 2023.
SL
Sharon Lew
Executive officer
SC
Sahani Chandraratna
Director
VV
Vidyasagar Vuligonda
Executive officer
MS
Martin Sanders
Chief Executive Officer
Earlier filings also listed Scott Thacher (director, last listed Jan 2014) and Roshantha Chandraratna (president and secretary, director, last listed Jan 2014).